Jun 12, 2024 • 7:30 AM EDT XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher
May 14, 2024 • 7:30 AM EDT XOMA to Present at H.C. Wainwright 2nd Annual Bioconnect Investor Conference at NASDAQ